Munafa Stock Market Course + Intraday & FNO calls 
Champions Oncology (CSBR) Technical (Analysis) Reports Champions Oncology ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Champions Oncology (CSBR)
Technical Analysis Report for NASDAQ stock CSBR Champions Oncology. Dated: 23 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CSBR Champions Oncology then click here. or read Experts views on Champions Oncology or Forecast & share price targets of Champions Oncology
Champions Oncology Opened at 6.10 and Closed at: 5.96, which is 1.51% of previous session's close. It moved within a range of 5.80 and 6.10
The session was a Bearish session with an average volume of 3300, which is 68.12% of previous session's volumes.
- There is some positive change in the short term trend, but its too soon to jump onto conclusions.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
A Golden cross was found 6 days back on short term averages
A Dead cross was found 7 days back on short term averages
A Golden cross was found 9 days back on short term averages
Support for tomorrow is 5.73 and resistance for tomorrow is 6.03
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 5.81, 5.65 resistance for tomorrow's hourly charts is 6.11, 6.25
10 Day SMA for Champions Oncology (CSBR) is 5.99 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Champions Oncology (CSBR) is 5.96 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Champions Oncology (CSBR) is 6.39 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 6.55 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Champions Oncology is 6.77 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Champions Oncology is at 5.96 and 200 DMA is at 6.77, while 50 DMA and 100 DMA are at 6.39 and 6.55 respectively
Champions Oncology (CSBR) moving average of 20 SMA is at 5.96 and 20 EMA is at 6.02
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Mon Mar | 5.96 | 5.96 | 6.02 |
| 20 Fri Mar | 5.87 | 5.95 | 6.03 |
| 19 Thu Mar | 6.03 | 5.96 | 6.05 |
| 17 Tue Mar | 6.20 | 5.95 | 6.05 |
| 16 Mon Mar | 6.25 | 5.93 | 6.03 |
| 13 Fri Mar | 6.10 | 5.92 | 6.01 |
Champions Oncology (CSBR) moving average of 50 SMA is at 6.39 and 50 EMA is at 6.25
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Mon Mar | 5.96 | 6.39 | 6.25 |
| 20 Fri Mar | 5.87 | 6.41 | 6.26 |
| 19 Thu Mar | 6.03 | 6.43 | 6.28 |
| 17 Tue Mar | 6.20 | 6.44 | 6.29 |
| 16 Mon Mar | 6.25 | 6.45 | 6.29 |
| 13 Fri Mar | 6.10 | 6.46 | 6.29 |
Champions Oncology (CSBR) moving average of 100 SMA is at 6.55 and 100 EMA is at 6.48
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Mon Mar | 5.96 | 6.55 | 6.48 |
| 20 Fri Mar | 5.87 | 6.56 | 6.49 |
| 19 Thu Mar | 6.03 | 6.57 | 6.5 |
| 17 Tue Mar | 6.20 | 6.57 | 6.51 |
| 16 Mon Mar | 6.25 | 6.58 | 6.52 |
| 13 Fri Mar | 6.10 | 6.58 | 6.53 |
Champions Oncology (CSBR) moving average of 200 SMA is at 6.77 and 200 EMA is at 6.62
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Mon Mar | 5.96 | 6.77 | 6.62 |
| 20 Fri Mar | 5.87 | 6.77 | 6.63 |
| 19 Thu Mar | 6.03 | 6.77 | 6.64 |
| 17 Tue Mar | 6.20 | 6.77 | 6.65 |
| 16 Mon Mar | 6.25 | 6.77 | 6.65 |
| 13 Fri Mar | 6.10 | 6.77 | 6.65 |
Xencor Inc has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Xencor Inc, about 2.27% more returns!
Champions Oncology has performed better than Verastem Inc in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Trinity Biotech in short term. Holding Champions Oncology could be a better choice for now!
Tonix Pharmaceuticals has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Tonix Pharmaceuticals, about 11.44% more returns!
Champions Oncology has performed better than Savara Inc in short term. Holding Champions Oncology could be a better choice for now!
Solid Biosciences has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Solid Biosciences, about 19.76% more returns!
Champions Oncology has performed better than Intellia Therapeutics in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Moleculin Biotech in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Agios Pharmaceuticals in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Alnylam Pharmaceuticals in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Amgen Inc in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Anixa Biosciences in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Arvinas Inc in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Autolus Therapeutics in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Biotelemetry Inc in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Enanta Pharmaceuticals in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology has performed better than Hologic Inc in short term. Holding Champions Oncology could be a better choice for now!
Inogen Inc has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Inogen Inc, about 11.68% more returns!
Champions Oncology Technical analysis of indicators
Price action analysis of Champions Oncology (CSBR) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Champions Oncology stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Champions Oncology in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Champions Oncology Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Champions Oncology in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Champions Oncology is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.02 and Champions Oncology CSBR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Champions Oncology CSBR stock. Volume based technical analysis of Champions Oncology CSBR stock is negative.
Champions Oncology Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CSBR Champions Oncology These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CSBR Experts View which covers a lot of information including buying and selling signals
CSBR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Champions Oncology or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Champions Oncology (CSBR) Technical (Analysis) Reports Champions Oncology ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
